The Cancer

Don't Miss

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Chris Draft mentioned sufferers with lung most cancers and their caregivers can regain management after analysis by displaying up, staying knowledgeable and leaning into advocacy,...

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Vital Information

Facts

Latest Articles

Presurgical Keytruda-Chemo Combo With Postsurgical Keytruda Could Enhance Survival in Early TNBC

Sufferers with early-stage triple-negative breast most cancers demonstrated improved survival outcomes after therapy with perioperative (time round surgical procedure) Keytruda (pembrolizumab) with chemotherapy,...

Chemotherapy De-Escalation Related With Wonderful HR+/HER2+ Breast Most cancers Survival

Sufferers with hormone receptor-positive (HR+)/HER2+ early breast most cancers who have been handled with neoadjuvant (presurgical) endocrine remedy or chemotherapy plus Herceptin (trastuzumab)...

Perioperative Imfinzi, Neoadjuvant Chemo Improves Survival in Muscle-Invasive Bladder Most cancers

Sufferers with cisplatin-eligible muscle-invasive bladder most cancers (MIBC) who acquired neoadjuvant (remedy as step one to shrink a tumor) Imfinzi (durvalumab) plus chemotherapy,...

Cyramza Plus Lonsurf Did Not Enhance Survival in Metastatic Colorectal Most cancers

Total survival didn't enhance with Cyramza plus Lonsurf, in contrast with Lonsurf alonh Lonsurf alone, e, in sufferers with closely pretreated metastatic colorectal...

Enhertu Maintains High quality of Life in Metastatic Breast Most cancers Subgroup

Sufferers with HR-positive, HER2-low or -ultralow metastatic breast most cancers (MBC) handled with Enhertu (trastuzumab deruxtecan) had a diminished deterioration in bodily/position functioning...

Hot Topics